Last updated on January 2019

A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)


Brief description of study

This is a Phase 3, randomized, double-blind, placebo-controlled, multinational, and multicenter study to evaluate the efficacy of rovalpituzumab tesirine as maintenance therapy following first-line platinum-based chemotherapy.

Clinical Study Identifier: NCT03033511

Contact Investigators or Research Sites near you

Start Over

ABBVIE CALL CENTER

Holy Cross Hospital /ID# 156716
Fort Lauderdale, FL United States
1.21miles
  Connect »

ABBVIE CALL CENTER

Memorial Cancer Institute /ID# 156673
Hollywood, FL United States
6.6miles
  Connect »

ABBVIE CALL CENTER

Memorial Cancer Institute /ID# 164052
Hollywood, FL United States
6.6miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.